echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Nature sub-journal: A common drug inhibits the spread of brain tumors

    Nature sub-journal: A common drug inhibits the spread of brain tumors

    • Last Update: 2022-08-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    UT Southwestern researchers have discovered a molecular pathway that causes glioblastoma to spread to tissues surrounding the bra.


    "The aggressiveness of glioblastoma may be the most formidable barrier to its treatment," said Amyn Habib, .


    Researchers at The University of Texas Southwestern have identified a molecular pathway that causes glioblastoma to spread to tissues surrounding the brain, and an existing drug that inhibits tumor growth in animal mode.


    Researchers have long believed that a protein on the surface of cells, the epidermal growth factor receptor (EGFR), is the driver of this canc.


    EGFR on glioblastoma cells can send these signals in two ways: either without prompting, in a state called constitutive signaling, or when stimulated by proteins called ligan.


    .




    Magazine

    natural cell biology


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.